- Filed
- May 2, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 25, 2025 | 26.81M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $8.34M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $19.56M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $350.95M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $357.1M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $831.61M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $820.27M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $418.18M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $387.12M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.63B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.59B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 26.88M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $7.02M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $4.29M |
| Capex | Q1 2025 · Mar 31, 2024 | $35.39M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$36.2M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $713.16M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $739.24M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.65 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.65 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $23.59M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$17.4M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $333.86M |